Skip to main content
. 2026 Jul 24;75(7):002189. doi: 10.1099/jmm.0.002189

Table 2. Average of inhibition zones of AB5075 mutants measured in mm (n=3) determined by Kirby–Bauer disc diffusion assays.

Aminoglycoside Tetracyclines β-Lactam Others
AK
30
CN
30
K
5
S
25
TOB
10
TE
30
TGC
15
IPM
10
MEM
10
DOR
10
CFP
30
CAZ
30
FEP
30
ATM
30
TIC
75
OX
1
FOX
30
TZP
110
CIP
5
C
30
SXT
25
F
100
E
15
VA
30
Wild-type 7 0 0 9 10 24 19 12 9 11 0 0 0 0 0 0 0 0 0 0 0 0 22 0
Δp1AB5075 21 20 17 16 18 22 17 13 10 12 0 19 0 7 0 0 0 0 0 7 25 0 20 0
Wild-type pWH1266 9.5 10 0 12 11 10 18 12 10 12 0 0 0 0 0 0 0 0 0 0 0 0 21 0
Δp1AB5075 pWH1266 24 21 19 15 18 10 19 12 9 12 0 17 18 8 0 0 0 0 0 7 26 0 19 0
Δp1AB5075 pWH1266-aadB 21 0 0 15 0 10 15 14 10 13 0 19 15 10 0 0 0 0 0 10 27 0 20 0
Δp1AB5075 pWH1266-adh 0 23 0 16 19 10 16 12 10 12 0 20 17 9 0 0 0 0 0 9 28 8 20 0
Δp1AB5075 pWH1266-aacA4 21 20 8 16 14 9 18 14 14 14 0 22 19 11 0 0 0 0 0 12 25 7 21 0
Δp1AB5075 pWH1266-aadA2 27 22 19 0 18 9 15 12 10 11 0 18 17 10 0 0 0 0 0 8 29 7 19 0
Δp1AB5075 pWH1266- strA 27 25 18 0 17 11 18 14 10 12 0 18 15 10 0 0 0 0 0 10 30 8 20 0
Δp1AB5075 pWH1266- strB 24 23 17 17 18 10 15 12 10 11 0 20 19 12 0 0 0 0 0 11 28 8 20 0
Δp1AB5075 pWH1266-blaGES-11 23 23 26 12 21 0 17 13 10 12 0 0 0 0 0 0 0 0 0 8 30 8 21 0

AK, amikacin; ATM, aztreonam; C, chloramphenicol; CAZ, ceftazidime; CFP, cefoperazone; CIP, ciprofloxacin; CN, gentamicin; DOR, doripenem; E, erythromycin; IPM, imipenem; K, kanamycin; MEM, meropenem; OX, oxacillin; S, streptomycin; SXT, trimethoprim/sulphamethoxazole; TE, tetracycline; TGC, tigecycline; TIC, ticarcillin; TOB, tobramycin; TZP, piperacillin/tazobactam; VA, vancomycin.